Scientific article

Role of matrix metalloproteinases in animal models of ischemic stroke

Published inCurrent vascular pharmacology, vol. 13, no. 2, p. 161-166
Publication date2015

Matrix metalloproteinases (MMP) comprise a family of at least 25 zinc-dependent endopeptidases that play a pivotal role in the physiopathology of the mammalian central nervous system. In the first phases after stroke, the dysregulation of MMPs has been described to increase acute neurovascular disruption and cerebral injury. In particular, MMP-mediated alterations lead to blood-brain barrier (BBB) leakage, cerebral edema, hemorrhage, leukocyte infiltration and progressive inflammatory reactions underlying brain tissue loss. In addition, MMPs have been also shown to play critical activities during the repair phases of cerebral ischemia, particularly during angiogenesis and reestablishment of cerebral blood flow. The aim of this narrative review is to elucidate the mechanisms by which MMPs may provide detrimental and/or beneficial effects during the post-stroke injury and repair phases in animal models.

Citation (ISO format)
LENGLET, Sébastien, MONTECUCCO, Fabrizio, MACH, François. Role of matrix metalloproteinases in animal models of ischemic stroke. In: Current vascular pharmacology, 2015, vol. 13, n° 2, p. 161–166. doi: 10.2174/15701611113116660161
ISSN of the journal1570-1611

Technical informations

Creation11/24/2015 12:13:00 PM
First validation11/24/2015 12:13:00 PM
Update time03/15/2023 12:26:00 AM
Status update03/15/2023 12:26:00 AM
Last indexation01/16/2024 9:00:06 PM
All rights reserved by Archive ouverte UNIGE and the University of GenevaunigeBlack